Race/Ethnicity and Clinical Outcomes in Breast Cancer

Transcript:

Joseph A. Sparano, MD: There was a very interesting presentation by Dr. Kathy Albain, one of the co-investigators of the TAILORx trial, that focused on the impact of race and ethnicity on clinical outcomes. And there were several really important conclusions that came from this. First of all, about 8% of the patients who enrolled in the trial were African American, and somewhere in the order of 12% or so were of Hispanic ethnicity. When we looked at the clinical characteristics of the black or Hispanic patients versus nonblack or white patients, and Hispanic versus non-Hispanic populations, the clinical characteristics were largely similar